Attached files
file | filename |
---|---|
EX-32.1 - EXHIBIT 32.1 - Cardiovascular Systems Inc | ex321-63018.htm |
EX-10.5 - EXHIBIT 10.5 - Cardiovascular Systems Inc | ex105-fy19execincentiveplan.htm |
EX-10.26 - EXHIBIT 10.26 - Cardiovascular Systems Inc | ex1026-executiveseverancep.htm |
EX-31.2 - EXHIBIT 31.2 - Cardiovascular Systems Inc | ex312-63018.htm |
EX-31.1 - EXHIBIT 31.1 - Cardiovascular Systems Inc | ex311-63018.htm |
EX-23.1 - EXHIBIT 23.1 - Cardiovascular Systems Inc | ex231-63018.htm |
EX-32.2 - EXHIBIT 32.2 - Cardiovascular Systems Inc | ex322-63018.htm |
EX-10.6 - EXHIBIT 10.6 - Cardiovascular Systems Inc | ex106fy19directorcompensatio.htm |
EX-10.57 - EXHIBIT 10.57 - Cardiovascular Systems Inc | ex1057-secondleaseamendmen.htm |
10-K - 10-K - Cardiovascular Systems Inc | csii10-kx63018.htm |
Exhibit 10.4
FISCAL YEAR 2019 EXECUTIVE OFFICER BASE SALARIES
The Company’s executive officers are scheduled to receive the following annual base salaries for the fiscal year ending June 30, 2019 in their current positions:
Name/Title | FY2019 Salary | |||||
Scott R. Ward Chairman, President and Chief Executive Officer | $ | 670,000 | ||||
Jeffrey S. Points Chief Financial Officer | $ | 302,500 | ||||
Rhonda J. Robb Chief Operating Officer | $ | 463,500 | ||||
Laura J. Gillund Chief Talent Officer | $ | 315,655 | ||||
Alexander Rosenstein General Counsel and Corporate Secretary | $ | 317,623 | ||||
Sandra M. Sedo Chief Compliance Officer | $ | 283,608 |